Nervous System Diseases
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) is 18years or above (2) had a stroke with an onset of 1 week to 12 months prior to the intervention (3) has FIM score of 55-100 (Level 3 moderate assistance) (4) total NIHSS score of 5 - 15 (moderate stroke). However, study participants would be excluded subject to these criteria
Exclusion criteria
Exclusion criteria: (1) has no access to a smartphone (2) is unavailable for follow-up interviews (3) has cognitive impairment that makes it difficult to comprehend information provided
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Based on the CONSORT checklist33 the pilot study is primarily aimed at assessing the preliminary feasibility and acceptability of the intervention in the Ghanaian context. Feasibility: Feasibility would be measured by retention rate, rate of adverse events and recording the details of resources used in implementing the intervention. Additionally, duration of sessions and cost of internet for the research team and study participants would be captured. Participant satisfaction: This will include the use of a 12-item questionnaire to assess the level of satisfaction of participants on delivery of the intervention, time spent, quality of audio-visual channels involved and overall perceived benefits.34 Participant experiences: Qualitative data of participant experiences would be captured in order to provide in-depth explanation of satisfaction levels. This would be guided by an interview probe designed for purpose. | — |
Secondary
| Measure | Time frame |
|---|---|
| Self-efficacy: The secondary and clinical outcome in focus would be Stroke Self-efficacy. The goal is assessed potential effectiveness of the intervention in improving self-efficacy among patients. This would be measured the Stroke Self Efficacy Questionnaire (SSEQ). The SSEQ is a 13-item scalar questionnaire that measures the stroke survivor’s ability and confidence in performing tasks under self-care, mobility and effective coping. The scale is also vital for assessing the functional performance of the study participants after the intervention. This tool is most appropriate because it has been proven to have good face validity with a Cronbach Alpha of 0.90 suggesting good internal consistency and higher criterion validity when compared with other self-efficacy scales. | — |
Countries
Ghana
Contacts
Graduate